Darvocet Lawsuit Filings in Federal MDL Begin to Mount

More than 100 Darvocet lawsuits and Darvon lawsuits have been filed in federal courts by plaintiffs who say that the drug’s side effects caused heart rhythm problems, and the number of cases is expected to continue growing. 

It has been just three months since a panel of federal judges ordered that the federal Darvocet litigation be consolidated and centralized in the U.S. District Court for the Eastern District of Kentucky as part of an MDL, or multi-district litigation.

At the time of the consolidation, there were 17 cases. According to recent court documents, that number has grown to more than 100.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

On November 18, plaintiff attorneys filed a motion to establish a common benefit fund. If approved, the fund would receive a percentage of any Darvocet settlement or recovery in every federal case and participating state court cases, disbursing funds to attorneys who performed work or incurred costs that benefit all plaintiffs. The request notes that Darvocet lawyers anticipate that hundreds more cases will ultimately be transferred to the MDL before the litigation is resolved.

All of the lawsuits over Darvocet and Darvon allege that the manufacturers of the recalled pain medication failed to adequately warn consumers or the medical community about the risk of serious and potentially fatal heart rhythm problems.

Darvocet was a popular pain medication that combines acetaminophen with propoxyphene, the active ingredient in the similar painkiller Darvon. The drugs were sold by Eli Lilly for about 40 years before distribution rights for the name brand version of the drug were sold to AAIPharma in 2002, and it was subsequently purchased by Xanodyne Pharmaceuticals in 2005. Generic versions of the medications are also available from a number of different drug makers

In November 2010, a Darvon and Darvocet recall was announced after the FDA concluded that side effects of propoxyphene can cause significant changes to the electrical activity of the heart.  The heart problems may increase the risk of heart arrythmias, myocardial infarction and sudden death. Both the brand name drugs and their generic equivalents were pulled from the market.

Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted today)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted yesterday)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.